Sign up for our FREE GI E-Weekly for more coverage like this sent to your inbox!
Cologuard is designed to detect DNA taken from a stool sample that indicates the presence of colorectal cancer or pre-cancerous polyps.
The results, determined during a DeeP-C clinical study, will be submitted to the FDA as part of the test’s pre-market approval process.
More Articles on Gastroenterology:
20 Statistics on Gastroenterologist Burnout
3 Statistics on Colonoscopy Procedure Times in ASCs
EndoSoft to Present GI Software at Digestive Disease Week in Orlando
